Insulin inhibits adrenal 17,20-lyase activity in man
- PMID: 1730815
- DOI: 10.1210/jcem.74.2.1730815
Insulin inhibits adrenal 17,20-lyase activity in man
Abstract
Experimentally induced hyperinsulinemia reduces serum adrenal androgen levels in man, but does not alter cortisol secretion. To determine whether insulin might selectively inhibit adrenal androgen production by suppressing 17,20-lyase activity, ACTH-stimulated androgen secretion was assessed in 10 normal men after an insulin infusion (hyperinsulinemic-euglycemic clamp) or a control saline infusion. For the insulin clamp study, each man received a 2-U (14.4-nmol) insulin bolus dose, followed by a 2.0-mU/kg.min (14.4-pmol/kg.min) insulin infusion for 5 h. An average insulin level of 746 +/- 35 (+/- SE) pmol/L was achieved; serum glucose was maintained at 4.96 +/- 0.03 mmol/L. At the end of the insulin infusion, an ACTH stimulation test was performed, and serum steroid levels were determined 30 and 60 min later. Subjects returned 1-3 weeks later for control studies, during which 0.45% saline was infused at rates matched exactly to the rates of the dextrose and insulin infusions during the insulin clamp studies, and an ACTH stimulation test was performed after 5 h of saline infusion. After the insulin infusion, stimulation by ACTH resulted in a significant rise in the serum molar ratio of 17 alpha-hydroxyprogesterone to androstenedione (from 0.914 +/- 0.110 at zero time to 1.388 +/- 0.278 60 min after ACTH; P less than 0.05), whereas no change occurred in the ACTH-stimulated ratio of these steroids after the saline infusion (1.067 +/- 0.109 at zero time to 1.060 +/- 0.109 60 min after ACTH; P = NS). The insulin-induced change in this steroid ratio was due to a relative increase in precursor (17 alpha-hydroxyprogesterone) and decrease in product (androstenedione) responsiveness to ACTH. Similarly, insulin treatment resulted in a greater than 100% rise in the difference from baseline in the serum molar ratio of 17 alpha-hydroxypregnenolone to dehydroepiandrosterone 30-60 min after ACTH (P less than 0.004), whereas no change in this difference was observed after the saline infusion (P = 0.71). Again, the insulin-induced change in this steroid ratio was due to a relative increase in precursor (17 alpha-hydroxypregnenolone) and decrease in product (dehydroepiandrosterone) responsiveness to ACTH. Of note, insulin treatment altered neither cortisol responsiveness to ACTH nor 17 alpha-hydroxylase activity, as indicated by similar ACTH-stimulated responses in the serum molar ratio of progesterone to 17 alpha-hydroxyprogesterone after the insulin and saline infusions (P = 0.71). Hence, the results of this study indicate that the acute elevation of serum insulin levels into the high physiological range selectively inhibits adrenal 17,20-lyase activity in man.
Similar articles
-
Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.J Clin Endocrinol Metab. 1996 Mar;81(3):881-6. doi: 10.1210/jcem.81.3.8772544. J Clin Endocrinol Metab. 1996. PMID: 8772544
-
Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time.J Clin Endocrinol Metab. 1990 May;70(5):1273-9. doi: 10.1210/jcem-70-5-1273. J Clin Endocrinol Metab. 1990. PMID: 2139878
-
Response of plasma adrenal steroids to synthetic ACTH under ketoconazole in man.Endocrinol Jpn. 1987 Feb;34(1):29-35. doi: 10.1507/endocrj1954.34.29. Endocrinol Jpn. 1987. PMID: 3038504
-
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women.Eur J Endocrinol. 2011 Feb;164(2):197-203. doi: 10.1530/EJE-10-0782. Epub 2010 Nov 8. Eur J Endocrinol. 2011. PMID: 21059865
-
Cytochrome P-450 as a target for therapeutic inhibitors.Biochem Soc Trans. 1993 Nov;21(4):1057-60. doi: 10.1042/bst0211057. Biochem Soc Trans. 1993. PMID: 8131897 Review. No abstract available.
Cited by
-
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.J Endocrinol Invest. 2009 Mar;32(3):210-8. doi: 10.1007/BF03346454. J Endocrinol Invest. 2009. PMID: 19542736 Free PMC article. Clinical Trial.
-
Dehydroepiandrosterone and diseases of aging.Drugs Aging. 1996 Oct;9(4):274-91. doi: 10.2165/00002512-199609040-00005. Drugs Aging. 1996. PMID: 8894525 Review.
-
Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.J Clin Invest. 1994 Oct;94(4):1484-9. doi: 10.1172/JCI117487. J Clin Invest. 1994. PMID: 7929824 Free PMC article. Clinical Trial.
-
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.J Endocrinol Invest. 1999 Feb;22(2):134-40. doi: 10.1007/BF03350893. J Endocrinol Invest. 1999. PMID: 10195381 Clinical Trial.
-
Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers.Diabetologia. 1993 Dec;36(12):1275-81. doi: 10.1007/BF00400805. Diabetologia. 1993. PMID: 8307255
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous